Brokerages Set Teladoc Health, Inc. (NYSE:TDOC) Price Target at $18.22

Teladoc Health, Inc. (NYSE:TDOC) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are presently covering the stock, MarketBeat.com reports. Twelve investment analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $18.22.

Several equities analysts have recently commented on the company. Royal Bank of Canada decreased their target price on Teladoc Health from $25.00 to $18.00 and set an “outperform” rating on the stock in a research report on Friday, April 26th. JPMorgan Chase & Co. cut their target price on Teladoc Health from $19.00 to $16.00 and set a “neutral” rating for the company in a research note on Tuesday, May 21st. Leerink Partnrs reiterated a “market perform” rating on shares of Teladoc Health in a research note on Monday, February 26th. Evercore ISI dropped their price target on Teladoc Health from $15.00 to $14.00 and set an “in-line” rating for the company in a research note on Friday, April 26th. Finally, Canaccord Genuity Group decreased their price objective on Teladoc Health from $28.00 to $25.00 and set a “buy” rating for the company in a report on Friday, April 26th.

Insider Buying and Selling at Teladoc Health

In other news, insider Daniel Trencher sold 6,780 shares of the company’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $98,445.60. Following the sale, the insider now directly owns 28,192 shares of the company’s stock, valued at approximately $409,347.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, insider Daniel Trencher sold 6,780 shares of the company’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $98,445.60. Following the sale, the insider now directly owns 28,192 shares of the company’s stock, valued at approximately $409,347.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Karen L. Daniel sold 9,834 shares of the stock in a transaction on Thursday, May 23rd. The stock was sold at an average price of $11.90, for a total transaction of $117,024.60. Following the sale, the director now directly owns 36,995 shares in the company, valued at $440,240.50. The disclosure for this sale can be found here. In the last quarter, insiders have sold 147,202 shares of company stock worth $2,085,611. 0.95% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Teladoc Health

A number of hedge funds have recently modified their holdings of the business. Vanguard Group Inc. increased its position in Teladoc Health by 11.8% during the fourth quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock worth $377,451,000 after purchasing an additional 1,855,480 shares during the last quarter. ARK Investment Management LLC increased its position in Teladoc Health by 4.5% during the fourth quarter. ARK Investment Management LLC now owns 21,224,565 shares of the health services provider’s stock worth $457,389,000 after purchasing an additional 912,692 shares during the last quarter. Dimensional Fund Advisors LP increased its position in Teladoc Health by 25.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider’s stock worth $82,636,000 after purchasing an additional 767,999 shares during the last quarter. Norges Bank acquired a new stake in Teladoc Health during the fourth quarter worth about $9,714,000. Finally, Charles Schwab Investment Management Inc. increased its position in Teladoc Health by 37.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,549,585 shares of the health services provider’s stock worth $28,807,000 after purchasing an additional 418,909 shares during the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Stock Up 0.3 %

Shares of Teladoc Health stock opened at $11.48 on Wednesday. The company has a quick ratio of 3.74, a current ratio of 3.82 and a debt-to-equity ratio of 0.67. Teladoc Health has a 12 month low of $11.32 and a 12 month high of $30.41. The business has a fifty day simple moving average of $13.58 and a 200 day simple moving average of $17.01. The stock has a market cap of $1.95 billion, a PE ratio of -8.14 and a beta of 0.97.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The business had revenue of $646.13 million for the quarter, compared to the consensus estimate of $637.31 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The business’s revenue was up 2.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.37) earnings per share. Research analysts predict that Teladoc Health will post -1.05 EPS for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.